$0.69
2.00% yesterday
Nasdaq, Jul 18, 10:00 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$0.69
-0.03 4.71% 1M
-0.01 1.15% 6M
-0.10 12.73% YTD
-0.48 41.37% 1Y
-5.49 88.90% 3Y
-6.22 90.07% 5Y
-118.11 99.42% 10Y
-5,363.31 99.99% 20Y
Nasdaq, Closing price Fri, Jul 18 2025
-0.01 2.00%
ISIN
US23725P1003
Symbol
DRIO
Sector

Key metrics

Basic
Market capitalization
$30.5m
Enterprise Value
$31.7m
Net debt
$1.2m
Cash
$28.1m
Shares outstanding
42.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 1.0
EV/Sales
1.1 | 1.0
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
60.6%
Return on Equity
-56.9%
ROCE
-51.0%
ROIC
-62.3%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$28.0m | $32.7m
EBITDA
$-41.8m | $-17.7m
EBIT
$-49.2m | $-35.9m
Net Income
$-38.6m | $-37.3m
Free Cash Flow
$-32.2m
Growth (TTM | estimate)
Revenue
47.2% | 20.9%
EBITDA
25.1% | 64.2%
EBIT
19.3% | 36.9%
Net Income
35.6% | 9.1%
Free Cash Flow
18.0%
Margin (TTM | estimate)
Gross
52.5%
EBITDA
-149.1% | -54.2%
EBIT
-175.4%
Net
-137.6% | -114.0%
Free Cash Flow
-115.0%
More
EPS
$-0.8
FCF per Share
$-0.8
Short interest
7.3%
Employees
199
Rev per Employee
$140.0k
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a DarioHealth Corp. forecast:

Buy
80%
Hold
20%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
28 28
47% 47%
100%
- Direct Costs 13 13
3% 3%
48%
15 15
181% 181%
53%
- Selling and Administrative Expenses 42 42
5% 5%
151%
- Research and Development Expense 22 22
0% 0%
77%
-42 -42
25% 25%
-149%
- Depreciation and Amortization 7.36 7.36
44% 44%
26%
EBIT (Operating Income) EBIT -49 -49
19% 19%
-175%
Net Profit -39 -39
36% 36%
-138%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
PRNewsWire
23 days ago
Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO , June 26, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ('Dario' or the 'Company'), a leader in the global digital health market, today announced a strategic commercial agreement with GreenKey Heal...
Neutral
PRNewsWire
25 days ago
Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in commercial discussions NEW YORK , June 24, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced four new stu...
Neutral
Seeking Alpha
2 months ago
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dodo - Acting Chief Operating Officer Conference Call Participants Charles Yi - TD Securities David Grossman - Stifel Nicolaus Operator Good morning, ladies and gentlemen, and welcome to the DarioHeal...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 199
Founded 2011
Website shop.mydario.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today